MedPath

comparison between dexamethasone and dexmedetomidine as an adjunct to ropivacaine in post operative shoulder surgery

Phase 4
Conditions
Health Condition 1: null- healthy patients with ASA grade 1-2
Registration Number
CTRI/2015/08/006124
Lead Sponsor
Government Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. ASA status 1-2

2. BMI - 18-30 kg/m2

3. Shoulder surgery such as rotator cuff repair, recurrent shoulder dislocations, acromioplasty, hemiarthroplasty and total shoulder replacement.

Exclusion Criteria

1. patient refusing to give informed consent

2. history of relevant drug allergy

3. history of psychiatric illness, substance abuse

4. severe cardiovascular, respiratory, metabolic or neurologic disease

5. pregnancy and lactation

6. coagulopathy

7. contralateral phrenic nerve dysfunction

8. infection at planned injection site

9.patients receiving alpha 2 agonists for hypertensive disorders

10.patients on steroids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
duration of post-operative analgesia as measured ( in minutes ) by the time from the achievement of adequate sensory block till the first use of fentanyl bolus by PCATimepoint: o hour- time at which adequate sensory block is achieved <br/ ><br>To time till the patient takes first dose of rescue analgesic( in 24 hours )
Secondary Outcome Measures
NameTimeMethod
pain ratings over 24 hours on 0-100 VAS , total post-operative analgesic consumption, patient satisfaction and adverse effects.Timepoint: 2 hourly monitoring after 4 hours of nerve block upto 24 hours .
© Copyright 2025. All Rights Reserved by MedPath